Multicolor Nanoparticles for Multiplexing of Lateral Flow Immunoassays

Technology #18118

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Image Gallery
A multiplexed assay strip  that is contacted with a liquid sample comprising labelled detection antibodies. This format is also known as a “dipstick” or “half strip” format. Multiplexed detection using AgNPs. Antibodies for viral proteins were printed on individual detection areas. A mixture of AgNP conjugated to anti-DENV NS1, anti-ZEBOV GP, and anti-YF NS1 was in the conjugate pad. When each of the infectious diseases is detected, the corresponding AgNPs forms a colored band at the specific line.
Categories
Inventors
Professor Lee Gehrke
Institute for Medical Engineering & Science, MIT
External Link (gehrkelab.org)
Kimberly Hamad-Schifferli
Department of Mechanical Engineering, MIT
Irene Bosch
Institute for Medical Engineering & Science, MIT
Helena De Puig Guixe
Department of Mechanical Engineering, MIT
Chun-wan Yen
Institute for Medical Engineering & Science, MIT
Justina Tam
Institute for Medical Engineering & Science, MIT
Managed By
Tod Woolf
MIT Technology Licensing Officer
Patent Protection

Multiplexed Lateral Flow Assay

PCT Patent Application Filed

Multiplexed Lateral Flow Assay

US Patent Pending
Publications
Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses.
Lab on a Chip, April, 2015, p.1638-1641

Applications

This technology can be used for sensitive detection of multiple analytes in a biological sample for highly accurate and low cost diagnostics.

Problem Addressed

Lateral flow assays (LFA), a type of immunoassay, are used for detection of analytes in biological samples. LFAs are robust and inexpensive, are easily transportable at ambient temperature, and do not require power or specialized reagents, making them ideal for point-of-care diagnostics. Furthermore, LFAs require only one step, whereas similar ELISA assays require multiple steps. 

Multiplexing, the detection of more than one biomarker in a single assay, is desirable because it increases speed, lowers costs, and allows the user to screen for multiple agents simultaneously. However, multiplexed LFAs are prone to false positive results due to the inability to discern the simultaneous responses of multiple labels. This technology is an improved multiplexed LFA design that is not only highly sensitive and easy to use, but also employs nanoparticles as novel detectible labels with numerous advantages outlined below.  


Technology

This technology comprises of a porous matrix strip that allows capillary flow, a sample pad to absorb the liquid sample, and a test area capable of detecting at least two analytes. The design also optionally includes either a positive or negative control area, a wick pad to absorb excess reagents, and backing or housing for the assay strip. The strip is small and portable, requiring only a minimal biological sample for quick detection, and requires little training for proper use. This invention is highly sensitive and is able to detect analytes in concentrations on the order of 1ng/ml and has successfully distinguished between dengue, yellow fever, and Ebola viruses, of which dengue and yellow fever belong to the same genus and family. While detection labels depend on intended detection methods, nanoparticles offer distinct advantages since they allow multiplexed analysis in a single channel and do not require an external excitation source. Furthermore, nanoparticles display different colors within the visible spectrum that may be tuned by varying their shape and size. Not only are these colors easy to distinguish by sight, they are also resistant to photobleaching. This invention may be paired with a simple mobile phone camera equipped with Red /Green / Blue analysis software for accessible and straightforward strip analysis, allowing this diagnostic assay to be especially functional in low-resource areas.

Advantages

  • Highly sensitive multiplexed assay can distinguish between multiple analytes
  • Flexible LFA design may include control, wick pad, or strip housing
  • Easy to transport and use
  • Does not require a cold chain for transport
  • Low cost and applicable to areas with few resources
  • Use of nanoparticles for labels means strip does not require excitation source and  is straightforward to diagnose